CD8A and neoplasm: To test this, we used GFP as a surrogate tumor Ag and co-cultured naïve anti-GFP JEDI CD8+ T cells25 with uninfected or NDV-preinfected mixtures of GFP+ and mCherry+ A20 cells (Fig. 1d).